SZSE:301033 (China)
Â
Class A
Â¥
43.74
(-0.52%)
Dec 23
Business Description
Medprin Regenerative Medical Technologies Co Ltd
ISIN : CNE100004NB8
Share Class Description:
SZSE:301033: Class ACompare
Compare
Traded in other countries / regions
301033.China IPO Date
2021-07-26Description
Medprin Regenerative Medical Technologies Co Ltd is engaged in the development and manufacturing of high-performance implanted medical devices.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 122.77 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 61.92 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 23.73 | |||||
| Beneish M-Score | -2.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.8 | |||||
| 3-Year EBITDA Growth Rate | 12.2 | |||||
| 3-Year EPS without NRI Growth Rate | -9.3 | |||||
| 3-Year Book Growth Rate | 12.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 49.56 | |||||
| Future 3-5Y Total Revenue Growth Rate | 29.48 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.05 | |||||
| 9-Day RSI | 35.31 | |||||
| 14-Day RSI | 39.41 | |||||
| 6-1 Month Momentum % | 17.55 | |||||
| 12-1 Month Momentum % | 7.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.34 | |||||
| Quick Ratio | 5.55 | |||||
| Cash Ratio | 3.99 | |||||
| Days Inventory | 202.15 | |||||
| Days Sales Outstanding | 17.83 | |||||
| Days Payable | 132.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.93 | |||||
| Dividend Payout Ratio | 0.39 | |||||
| Forward Dividend Yield % | 0.93 | |||||
| 5-Year Yield-on-Cost % | 0.93 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 2.02 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.91 | |||||
| Operating Margin % | 27.88 | |||||
| Net Margin % | 24.73 | |||||
| FCF Margin % | 23.42 | |||||
| ROE % | 10.68 | |||||
| ROA % | 9.04 | |||||
| ROIC % | 12.3 | |||||
| ROC (Joel Greenblatt) % | 24.19 | |||||
| ROCE % | 11.65 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 42.28 | |||||
| Forward PE Ratio | 33.56 | |||||
| PE Ratio without NRI | 42.4 | |||||
| Price-to-Owner-Earnings | 1465.66 | |||||
| PS Ratio | 10.35 | |||||
| PB Ratio | 4.38 | |||||
| Price-to-Tangible-Book | 5.1 | |||||
| Price-to-Free-Cash-Flow | 44.02 | |||||
| Price-to-Operating-Cash-Flow | 28.61 | |||||
| EV-to-EBIT | 34.63 | |||||
| EV-to-EBITDA | 34.63 | |||||
| EV-to-Revenue | 10.3 | |||||
| EV-to-FCF | 44 | |||||
| Price-to-Graham-Number | 3.06 | |||||
| Price-to-Net-Current-Asset-Value | 14.02 | |||||
| Price-to-Net-Cash | 28.97 | |||||
| Earnings Yield (Greenblatt) % | 2.89 | |||||
| FCF Yield % | 2.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medprin Regenerative Medical Technologies Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 276.032 | ||
| EPS (TTM) (Â¥) | 1.04 | ||
| Beta | 0.86 | ||
| Volatility % | 41.1 | ||
| 14-Day RSI | 39.41 | ||
| 14-Day ATR (Â¥) | 1.723748 | ||
| 20-Day SMA (Â¥) | 46.489 | ||
| 12-1 Month Momentum % | 7.47 | ||
| 52-Week Range (Â¥) | 22.37 - 57.32 | ||
| Shares Outstanding (Mil) | 66.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medprin Regenerative Medical Technologies Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medprin Regenerative Medical Technologies Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medprin Regenerative Medical Technologies Co Ltd Frequently Asked Questions
What is Medprin Regenerative Medical Technologies Co Ltd(SZSE:301033)'s stock price today?
The current price of SZSE:301033 is ¥43.74. The 52 week high of SZSE:301033 is ¥57.32 and 52 week low is ¥22.37.
When is next earnings date of Medprin Regenerative Medical Technologies Co Ltd(SZSE:301033)?
The next earnings date of Medprin Regenerative Medical Technologies Co Ltd(SZSE:301033) is .
Does Medprin Regenerative Medical Technologies Co Ltd(SZSE:301033) pay dividends? If so, how much?
The Dividend Yield %  of Medprin Regenerative Medical Technologies Co Ltd(SZSE:301033) is 0.93% (As of Today), Highest Dividend Payout Ratio of Medprin Regenerative Medical Technologies Co Ltd(SZSE:301033) was 0.39. The lowest was 0.28. And the median was 0.32. The  Forward Dividend Yield % of Medprin Regenerative Medical Technologies Co Ltd(SZSE:301033) is 0.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers